Works matching DE "SARALASIN"

Results: 115

Serum levels of interleukin 6 in schizophrenic patients during treatment augmentation with sarcosine (results of the PULSAR study).

Published in:

Human Psychopharmacology: Clinical & Experimental, 2018, v. 33, n. 2, p. 1, doi. 10.1002/hup.2652

By:

Strzelecki, Dominik;
Urban‐Kowalczyk, Małgorzata;
Wysokiński, Adam

Publication type:

Article

Issue Information.

Published in:: Human Psychopharmacology: Clinical & Experimental, 2018, v. 33, n. 2, p. 1, doi. 10.1002/hup.2636
Publication type:: Article

In Vitro Method of Studying the Angiotensin Activity of Chemical Compounds.

Published in:

Bulletin of Experimental Biology & Medicine, 2014, v. 158, n. 1, p. 115, doi. 10.1007/s10517-014-2705-8

By:

Spasov, A.;
Yakovlev, D.;
Bukatina, T.;
Brigadirova, A.

Publication type:

Article

Reactive Hyperreninemia in Renovascular Hypertension After Angiotensin Blockade with Saralasin or Converting Enzyme Inhibitor.

Published in:

Annals of Internal Medicine, 1979, v. 91, n. 2, p. 153, doi. 10.7326/0003-4819-91-2-153

By:

Case, David B.;
Laragh, John H.

Publication type:

Article

Effect of saralasin in hypertensive patients on chronic hemodialysis.

Published in:

1978

By:

Lifschitz, Meyer D.;
Kirschenbaum, Michael A.;
Rosenblatt, Steven G.;
Gibney, Richard;
Lifschitz, M D;
Kirschenbaum, M A;
Rosenblatt, S G;
Gibney, R

Publication type:

journal article

Diuretic Therapy and Response of Essential Hypertension to Saralasin.

Published in:

Annals of Internal Medicine, 1977, v. 87, n. 2, p. 183, doi. 10.7326/0003-4819-87-2-183

By:

Anderson Jr., Gunnar H.;
Dalakos, Theodore G.;
Elias, Alan;
Tomycz, Nestor;
Streeten, David H. P.

Publication type:

Article

Renin, Sodium, and Vasodepressor Response to Saralasin in Renovascular and Essential Hypertension.

Published in:

Annals of Internal Medicine, 1977, v. 87, n. 2, p. 176, doi. 10.7326/0003-4819-87-2-176

By:

Marks, Leonard S.;
Maxwell, Morton H.;
Kaufman, Joseph I.

Publication type:

Article

Saralasin infusion in the recognition of renovascular hypertension.

Published in:

1977

By:

Wilson, Hugh M.;
James P. Wilson;
Paul E. Slaton;
John H. Foster;
Grant W. Liddle;
John W. Hollifield;
Wilson, H M;
Wilson, J P;
Slaton, P E;
Foster, J H;
Liddle, G W;
Hollifield, J W

Publication type:

journal article

Angiotensin blockade in hypertension.

Published in:

1977

By:

Streeten, David H. P.;
Anderson, Gunnar H.;
Streeten, D H;
Anderson, G H

Publication type:

Editorial

Microalbuminuria in hypertensive patients: Evaluation of one-year treatment with irbesartan.

Published in:

Kidney International Supplement, 2005, n. 93, p. S29, doi. 10.1111/j.1523-1755.2005.09307.x

By:

de Álvaro, Fernando;
Velasco, Olga;
Honorato, Jesús;
Calvo, Carlos;
Parrondo, Inma

Publication type:

Article

Effect of a converting enzyme inhibitor, angiotensin II, and saralasin on glomerular hemodynamics.

Published in:

Kidney International Supplement, 1990, n. 30, p. S-74, doi. 10.1111/1523-1755.ep17660355

By:

Heller, Jiř;
Horačk, Vladislav

Publication type:

Article

Angiotensin II profiling with saralasin: Summary of Eaton Collaborative Study.

Published in:

Kidney International Supplement, 1979, n. 9, p. 115, doi. 10.1111/1523-1755.ep17656352

By:

Horne, Melvin L.;
Conklin, Vincent M.;
Keenan, Robert E.;
Varady, Paul D.;
DiNardo, Joseph

Publication type:

Article

Comparison between saralasin and converting enzyme inhibitor in hypertensive disease.

Published in:

Kidney International Supplement, 1979, n. 9, p. 107, doi. 10.1111/1523-1755.ep17656349

By:

Case, David B.;
Wallace, John M.;
Laragh, John H.

Publication type:

Article

Drug interactions with saralasin.

Published in:

Kidney International Supplement, 1979, n. 9, p. 101, doi. 10.1111/1523-1755.ep17656348

By:

Mitchell, Helen C.;
Keeton, T. Kent;
Pettinger, William A.

Publication type:

Article

Use of saralasin in end-stage renal disease.

Published in:

Kidney International Supplement, 1979, n. 9, p. 93, doi. 10.1111/1523-1755.ep17656347

By:

Fadem, Stephen Z.;
Lifschitz, Meyer D.

Publication type:

Article

Physiologic definition of blood pressure response to renal revascularization in patients with renovascular hypertension.

Published in:

Kidney International Supplement, 1979, n. 9, p. 83, doi. 10.1111/1523-1755.ep17656346

By:

Vaughan Jr., E. Darracott;
Carey, Robert M.;
Ayers, Carlos R.;
Peach, Michael J.;
Tegtmeyer, Charles J.;
Wellons Jr., Harry A.

Publication type:

Article

Angiotensin II blockade by saralasin in the evaluation of hypertension in children.

Published in:

Kidney International Supplement, 1979, n. 9, p. 75, doi. 10.1111/1523-1755.ep17656014

By:

Favre, Laurent;
Boerth, Robert C.;
Braren, Victor;
Dean, Richard H.;
Hollifield, John W.

Publication type:

Article

Hemodynamic correlates of saralasin: Responsiveness in hypertension.

Published in:

Kidney International Supplement, 1979, n. 9, p. 68, doi. 10.1111/1523-1755.ep17656008

By:

Kem, David C.;
Frohlich, Edward D.;
de Carvalho, Jose G. R.;
Dunn, Francis G.;
Chrysant, Steven G.;
Danisa, Kola;
Wambach, Gerhard

Publication type:

Article

Angiotensin blockade by saralasin bolus injection.

Published in:

Kidney International Supplement, 1979, n. 9, p. 53, doi. 10.1111/1523-1755.ep17655892

By:

Maxwell, Morion H.;
Marks, Leonard S.

Publication type:

Article

Outpatient experience with saralasin.

Published in:

Kidney International Supplement, 1979, n. 9, p. 44, doi. 10.1111/1523-1755.ep17655885

By:

Streeten, David H. P.;
Anderson Jr., Gunnar H.

Publication type:

Article

Saralasin in human hypertension: The early experience.

Published in:

Kidney International Supplement, 1979, n. 9, p. 36, doi. 10.1111/1523-1755.ep17655876

By:

Brunner, Hans R.;
Laragh, John H.

Publication type:

Article

Angiotensin as a renal, adrenal, and cardiovascular hormone: Responses to saralasin in normal man and in essential and secondary hypertension.

Published in:

Kidney International Supplement, 1979, n. 9, p. 29, doi. 10.1111/1523-1755.ep17655863

By:

Hollenberg, Norman K.;
Williams, Gordon H.

Publication type:

Article

Physiologic studies with saralasin in animals.

Published in:

Kidney International Supplement, 1979, n. 9, p. 20, doi. 10.1111/1523-1755.ep17655845

By:

Gavras, Haralambos;
Gavras, Irene;
Brunner, Hans R.;
Chang-Seng Liang

Publication type:

Article

Preclinical pharmacology of saralasin.

Published in:

Kidney International Supplement, 1979, n. 9, p. 11, doi. 10.1111/1523-1755.ep17655804

By:

Castellion, Alan W.;
Fulton, Robert W.

Publication type:

Article

Historical development of saralasin.

Published in:

Kidney International Supplement, 1979, n. 9, p. 7, doi. 10.1111/1523-1755.ep17655791

By:

Pals, Donald T.;
Denning Jr., George S.;
Keenan, Robert E.

Publication type:

Article

Synthesis of dispiro[oxindole-pyrrolidine]-thiazolo[3,2- a][1,3,5]triazines by 1,3-dipolar cycloaddition.

Published in:

Journal of Heterocyclic Chemistry, 2011, v. 48, n. 4, p. 836, doi. 10.1002/jhet.647

By:

Xiaofang Li;
Zhikui Li;
Aiting Zheng;
Guobin Li;
Xianyong Yu;
Pinggui Yi

Publication type:

Article

Valsartan Abolishes Most of the Memory-Improving Effects of Intracerebroventricular Angiotensin II in Rats.

Published in:

Clinical & Experimental Hypertension, 2005, v. 27, n. 8, p. 635, doi. 10.1080/10641960500298723

By:

Braszko, Jan J.

Publication type:

Article

Cardiovascular Pharmacotherapy in Patients with Marfan Syndrome.

Published in:

American Journal of Cardiovascular Drugs, 2007, v. 7, n. 2, p. 117, doi. 10.2165/00129784-200707020-00003

By:

Yetman, Anji T.

Publication type:

Article

Angiotensin II Receptor Antagonists Alone and Combined with Hydrochlorothiazide: Potential Benefits Beyond the Antihypertensive Effect.

Published in:

American Journal of Cardiovascular Drugs, 2005, v. 5, n. 3, p. 171, doi. 10.2165/00129784-200505030-00004

By:

Meredith, Peter A.

Publication type:

Article

Fixed-Dose Combinations in the Management of Hypertension: Defining the Place of Angiotensin Receptor Antagonists and Hydrochlorothiazide.

Published in:

American Journal of Cardiovascular Drugs, 2005, v. 5, n. 1, p. 17, doi. 10.2165/00129784-200505010-00003

By:

Kjeldsen, Sverre E.;
Os, Ingrid;
Høieggen, Aud;
Beckey, Kim;
Gleim, Gilbert W.;
Oparil, Suzanne

Publication type:

Article

Prospective evaluation of serum sarcosine and risk of prostate cancer in the Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial.

Published in:

Carcinogenesis, 2013, v. 34, n. 10, p. 2281, doi. 10.1093/carcin/bgt176

By:

Koutros, Stella;
Meyer, Tamra E.;
Fox, Stephen D.;
Issaq, Haleem J.;
Veenstra, Timothy D.;
Huang, Wen-Yi;
Yu, Kai;
Albanes, Demetrius;
Chu, Lisa W.;
Andriole, Gerald;
Hoover, Robert N.;
Hsing, Ann W.;
Berndt, Sonja I.

Publication type:

Article

Comparison of Angiotensin II Type 1 Receptor Antagonists in the Treatment of Essential Hypertension.

Published in:

Drugs, 2008, v. 68, n. 9, p. 1207, doi. 10.2165/00003495-200868090-00003

By:

Smith, David H. G.

Publication type:

Article

Preparation, Characterization, and Antimicrobial Activities of Bimetallic Complexes of Sarcosine with Zn(II) and Sn(IV).

Published in:

Bioinorganic Chemistry & Applications, 2013, p. 1, doi. 10.1155/2013/351262

By:

Arafat, Yasir;
Ali, Saqib;
Shahzadi, Saira;
Shahid, Muhammad

Publication type:

Article

Baroreceptor Reflex Regulation in Anesthetized Older Transgenic Rats with Low Brain Angiotensinogen: Role of Endogenous Angiotensin II and Angiotensin-(1- 7).

Published in:

FASEB Journal, 2007, v. 21, n. 6, p. A889, doi. 10.1096/fasebj.21.6.a889-a

By:

Arnold, Amy C.;
Sakima, Atsushi;
Ganten, Detlev;
Ferrario, Carlos M.;
Diz, Debra I.

Publication type:

Article

3,6-Bis(5'-bromo-3'-indolyl)-1,4-dimethypiperazine-2,5-dione.

Published in:

Molbank, 2009, v. 9, n. 4, p. 1

By:

Crooke, Stephen;
Davis-McGibony, Michele;
Whitlock, Christine

Publication type:

Article

Fingernail Clubbing and Chromonychia Associated with the Use of Angiotensin II Receptor Blockers.

Published in:

Pharmacotherapy, 2004, v. 24, n. 4, p. 546, doi. 10.1592/phco.24.5.546.33345

By:

Packard, Kathleen A.;
Arouni, Amy J.;
Hilleman, Daniel E.;
Gannon, Joshua M.

Publication type:

Article

GNMT Expression Increases Hepatic Folate Contents and Folate-Dependent Methionine Synthase-Mediated Homocysteine Remethylation.

Published in:

Molecular Medicine, 2011, v. 17, n. 5/6, p. 486, doi. 10.2119/molmed.2010.00243

By:

Yi-Cheng Wang;
Yi-Ming Chen;
Yan-Jun Lin;
Shih-Ping Liu;
Chiang, En-Pei Isabel

Publication type:

Article

PERIPHERAL VASCULAR REACTIVITY TO ANGIOTENSIN AND NORADRENALINE IN PREGNANT AND NON--PREGNANT WOMEN.

Published in:

Australian Journal of Experimental Biology & Medical Science, 1970, v. 48, n. 5, p. 493, doi. 10.1038/icb.1970.49

By:

Lumbers, Eugenie K.

Publication type:

Article

Mutations in the sarcosine dehydrogenase gene in patients with sarcosinemia.

Published in:

Human Genetics, 2012, v. 131, n. 11, p. 1805, doi. 10.1007/s00439-012-1207-x

By:

Bar-joseph, Ifat;
Pras, Elon;
Reznik-Wolf, Haike;
Marek-Yagel, Dina;
Abu-Horvitz, Almogit;
Dushnitzky, Maya;
Goldstein, Nurit;
Rienstein, Shlomit;
Dekel, Michal;
Pode-Shakked, Ben;
Zlotnik, Joseph;
Benarrosh, Anelia;
Gillery, Philippe;
Hofliger, Niklaus;
Auray-Blais, Christiane;
Garnotel, Roselyne;
Anikster, Yair

Publication type:

Article

Blocking the tissue renin-angiotensin system: the future cornerstone of therapy.

Published in:

Journal of Human Hypertension, 2000, v. 14, n. 10/11, p. S23, doi. 10.1038/sj.jhh.1001070

By:

Unger, T;
Azizi, M;
Belz, G G

Publication type:

Article

The role of angiotensin II receptor antagonists in hypertension management: focus on candesartan cilexetil.

Published in:

Journal of Human Hypertension, 2000, v. 14, n. 10/11, p. S3, doi. 10.1038/sj.jhh.1001072

By:

Mancia, G;
Grassi, G

Publication type:

Article

Putting the efficacy of candesartan cilexetil into perspective: a review of new comparative data.

Published in:

Journal of Human Hypertension, 2000, v. 14, n. 10/11, p. S33, doi. 10.1038/sj.jhh.1001073

By:

Mallion, J M;
Baguet, J P

Publication type:

Article

The do's and don'ts when using AIIRAs in daily practice in hypertension: an introduction.

Published in:

Journal of Human Hypertension, 2000, v. 14, n. 10/11, p. S1, doi. 10.1038/sj.jhh.1001103

By:

Sever, P S

Publication type:

Article

Discussion 2 (Part A).

Published in:: Journal of Human Hypertension, 1999, v. 13, n. 1, p. S49, doi. 10.1038/sj.jhh.1000751
Publication type:: Article

Discussion 2 (Part B).

Published in:: Journal of Human Hypertension, 1999, v. 13, n. 1, p. S61, doi. 10.1038/sj.jhh.1000752
Publication type:: Article

Angiotensin II antagonists: efficacy, duration of action, comparison with other drugs.

Published in:

Journal of Human Hypertension, 1998, v. 12, n. 5, p. 271, doi. 10.1038/sj.jhh.1000637

By:

Elliott, H L

Publication type:

Article

Angiotensin-II receptor antagonist: A new class of antihypertensive agents.

Published in:

American Family Physician, 1996, v. 53, n. 2, p. 589

By:

Weir, Matthew R.

Publication type:

Article

AAP Guidelines for Achondroplasia Angiotensin-II Blockers for Hypertension.

Published in:: American Family Physician, 1995, v. 52, n. 1, p. 300
Publication type:: Article

Reduction of Microalbuminuria in Patients With Type 2 Diabetes.

Published in:

Diabetes Care, 2007, v. 30, n. 6, p. 1581, doi. 10.2337/dc06-2493

By:

Kashiwagi, Atsunori

Publication type:

Article

Electropharmacological properties of telmisartan in blocking hKv1.5 and HERG potassium channels expressed on Xenopus laevis oocytes.

Published in:

Acta Pharmacologica Sinica, 2008, v. 29, n. 8, p. 913, doi. 10.1111/j.1745-7254.2008.00839.x

By:

Dan-na Tu;
Yu-hua Liao;
An-ruo Zou;
Yi-mei Du;
Qi Run;
Xian-pei Wang;
Lu Li

Publication type:

Article